索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]刘相飞,马晓羽,王琎,等.Marshall 静脉无水乙醇消融在心房颤动射频消融中的应用[J].国际心血管病杂志,2022,06:382.
点击复制

Marshall 静脉无水乙醇消融在心房颤动射频消融中的应用(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2022年06期
页码:
382
栏目:
经验交流
出版日期:
2022-12-20

文章信息/Info

Title:
-
作者:
刘相飞; 马晓羽; 王琎; 倪周
257031 东营，胜利油田中心医院（刘相飞，马晓羽，倪 周）；450052 郑州大学第一附属医院心内科（王琎）
Author(s):
-
关键词:
Marshall 静脉; 酒精消融; 阵发性房颤; 导管消融
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2022.06.018
文献标识码:
-
摘要:
目的：比较Marshall 静脉无水乙醇消融联合导管射频消融与单纯导管射频消融 术对治疗阵发性心房颤动（房颤）的有效性和安全性。 方法：将阵发性房颤患者分为对照 组（单纯行导管射频消融术296 例）和试验组（无水乙醇消融联合导管射频消融术103 例）。 观察2 组术后 6、12 个月时房颤复发情况, 比较2 组手术主要并发症情况。 结果：术后 6 个月时，试验组与对照组的房颤复发率无统计学差异，但术后12 个月时，试验组的复发率 显著低于对照组（15.54% 对28.4%，P＜0.05）。2 组手术后主要并发症比较均无统计学差 异。 结论：Marshall 静脉无水乙醇消融联合导管射频消融治疗阵发性房颤安全、可靠，其 远期疗效优于单纯行导管射频消融术。
Abstract:
-

参考文献/References

[1] Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS[J]. Rev Esp Cardiol (Engl Ed), 2017, 70(1):50.
[2] Yokokawa M, Chugh A, Latchamsetty R, et al. Cryoballoon antral pulmonary vein isolation vs contact force-sensing radiofrequency catheter ablation for pulmonary vein and posterior left atrial isolation in patients with persistent atrial fibrillation[J]. Heart Rhythm, 2018, 15(12):1835-1841.
[3] Smit MD, Maass AH, De Jong AM, et al. Role of inflammation in early atrial fibrillation recurrence[J]. Europace, 2012, 14(6): 810-817.
[4] Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary[J]. Heart Rhythm, 2017, 14(10):e445-e494.
[5] Ouyang FF, Tilz R, Chun JL, et al. Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up[J]. Circulation, 2010, 122(23):2368-2377.
[6] Tzou WS, Marchlinski FE, Zado ES, et al. Longterm outcome after successful catheter ablation of atrial fibrillation[J]. Circ Arrhythm Electrophysiol, 2010, 3(3):237-242.
[7] Derval N, Duchateau J, Denis A, et al. Marshall bundle elimination, Pulmonary vein isolation, and Line completion for ANatomical ablation of persistent atrial fibrillation (Marshall- PLAN): prospective, single-center study[J]. Heart Rhythm, 2021, 18(4):529-537.
[8] Makino M, Inoue S, Matsuyama TA, et al. Diverse myocardial extension and autonomic innervation on ligament of Marshall in humans[J]. J Cardiovasc Electrophysiol, 2006, 17(6):594- 599.
[9] Hou YL, Scherlag BJ, Lin JX, et al. Ganglionated plexi modulate extrinsic cardiac autonomic nerve input: effects on sinus rate, atrioventricular conduction, refractoriness, and inducibility of atrial fibrillation[J]. J Am Coll Cardiol, 2007, 50(1):61-68.
[10] Yu XM, He WB, Qin ZL, et al. Selective ablation of the ligament of Marshall attenuates atrial electrical remodeling in a short-term rapid atrial pacing canine model[J]. J Cardiovasc Electrophysiol, 2018, 29(9):1299-1307.
[11] Valderrábano M, Chen HR, Sidhu J, et al. Retrograde ethanol infusion in the vein of Marshall: regional left atrial ablation, vagal denervation and feasibility in humans[J]. Circ Arrhythm Electrophysiol, 2009, 2(1):50-56.
[12] Valderrábano M, Peterson LE, Bunge R, et al. Vein of marshall ethanol infusion for persistent atrial fibrillation: Venus and Mars clinical trial design[J]. Am Heart J, 2019, 215:52-61.
[13] Lai YW, Liu XX, Sang CH, et al. Effectiveness of ethanol infusion into the vein of Marshall combined with a fixed anatomical ablation strategy (the "upgraded 2C3L" approach) for catheter ablation of persistent atrial fibrillation[J]. J Cardiovasc Electrophysiol, 2021, 32(7):1849-1856.
[14] Kamakura T, Derval N, Duchateau J, et al. Vein of marshall ethanol infusion: feasibility, pitfalls, and complications in over 700 patients[J]. Circ Arrhythm Electrophysiol, 2021, 14(8): e010001.

备注/Memo

备注/Memo:
基金项目：山东省医药卫生科技发展计划项目（202103010895）
通信作者：刘相飞， E-mail：zhaoyang20023903@126.com
更新日期/Last Update: 2022-12-20